Visugromab in Cachexia International Trial
Eligible age
18+ yrs
Accepts
All genders
Locations
5 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A study of how well and safely a new drug called visugromab works in people with certain kinds of cancer (including lung and bowel cancer) and unintended weight loss known as cachexia. The main questions it aims to answer are: * Does visugromab help participants put weight back on and have a better appetite? * Does visugromab help participants move more and better? * What medical problems do participants have when taking visugromab? Researchers will compare visugromab to a placebo (a look-alike substance that contains no drug). Participants will visit the hospital or clinic once every 4 weeks to receive visugromab or placebo via a drip into a vein and to undergo checkups and tests.
Sponsor: CatalYm GmbH
You may qualify if…
- ✓ Weight loss
- ✓ Advanced cancer
You may not qualify if…
- ✕ Participation in another interventional clinical trial, receipt of any investigational therapy or use of any investigational device within 4 weeks prior to screening and between screening and the first dose of investigational product
Where it's recruiting
Norwich
Clermont · Orange City · Stuart
Augusta
East Brunswick
Avon · Cleveland · Fairview · Mayfield Heights
Source: ClinicalTrials.gov · NCT07112196 · last updated 2026-08-10